Search results - 7 results
Epidemiology and genotype 3 subtype dynamics of hepatitis E virus in Belgium, 2010 to 2017.
Thomas; Bernard Brochier; Lorenzo Subissi; Steven Van Gucht Source: Euro Surveill, Volume 24, Issue 10 (2019) Keywords: hepatitis E; HEV; surveillance; epidemiology; genotype; Belgium Abstract: ...
Low hepatitis C prevalence in Belgium: implications for treatment reimbursement and scale up.
clustered sampling. RESULTS: In total 3209 specimens, collected by 28 laboratories, were tested. HCV seropositivity in the Belgian general population was estimated to be 0.22% (95% CI: 0.09-0.54%), and prevalence of ...
Subtype-specific differences in the risk of hospitalisation among patients infected with hepatitis E virus genotype 3 in Belgium, 2010-2018.
Publication Type: Peer reviewed scientific article Authors: Lorenzo Subissi; Michael Peeters; Lamoral, Sophie; Sofieke Klamer; Vanessa Suin; Steven Van Gucht Source: Epidemiol Infect, Volume 147 ...
Distribution of HCV genotypes in Belgium from 2008 to 2015.
Nicolas Hougardy; Lagrou, Katrien; Els Oris; Padalko, Elizaveta; Marijke Reynders; Gatien Roussel; Jean-Marc Senterre; Michel Stalpaert; Dominique Ursi; Carl Vael; Vaira, Dolorès; Van Acker, Jos; Walter ...
Hepatitis E virus serology and PCR: does the methodology matter?
Colle, Isabelle; Veronik Hutse; Vanessa Suin; Wautier, Magali; Steven Van Gucht; Van Vlierberghe, Hans; Padalko, Elizaveta Source: Arch Virol, Volume 162, Issue 9, p.2625-2632 (2017) Keywords: Antibodies, ...
Oral fluid as a detection tool for viral infections- application in public health?
Publication Type: Dissertation Authors: Veronik Hutse Source: UA, Antwerp, Belgium, p.232 (2015) Accession Number: NA Keywords: Hepatitis Measles Oral fluid Rubella Saliva VIRUS Health Topics: ...
Diagnostic hepatitis C testing of people in treatment for substance use disorders in Belgium between 2011 and 2014: a cross-sectional study.
out of 30,905 patients (61.1%) in treatment for substance use disorders between 2011 and 2014 have been screened at least once for HCV between 2008 and 2015. 58.0% of those who had never injected and ...